autologous Epstein-Barr virus-transformed B-lymphoblastoid cell vaccine
Term · Oncology and biomedicine · MLC-T-ONC-011622
A cell-based vaccine composed of autologous lymphoblastoid B cells activated against Epstein-Barr virus (EBV) in vitro with potential immunoprotective activity. Upon prophylactic administration, this vaccine may stimulate specific cytotoxic T-lymphocyte (CTL) and antibody responses against EBV-transformed B cells, thereby preventing an EBV-induced post-transplantation lymphoproliferative disorder.
| Identifier | MLC-T-ONC-011622 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous EBV-transformed B-lymphoblastoid cell vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011622",
"term": "autologous Epstein-Barr virus-transformed B-lymphoblastoid cell vaccine",
"field": "Oncology and biomedicine",
"definition": "A cell-based vaccine composed of autologous lymphoblastoid B cells activated against Epstein-Barr virus (EBV) in vitro with potential immunoprotective activity. Upon prophylactic administration, this vaccine may stimulate specific cytotoxic T-lymphocyte (CTL) and antibody responses against EBV-transformed B cells, thereby preventing an EBV-induced post-transplantation lymphoproliferative disorder.",
"synonyms": [
"autologous EBV-transformed B-lymphoblastoid cell vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-epstein-barr-virus-transformed-b-lymphoblastoid-cell-vaccine/"
}
Record 2,956 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.